Healthcare provider profile · identity verified

Suzin M Hagar, MD

Family Practice · MEDFORD, OR · NPI 1447260666

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	614	164
Losartan Potassium	Losartan Potassium	428	115
Levothyroxine Sodium	Levothyroxine Sodium	422	109
Rosuvastatin Calcium	Rosuvastatin Calcium	367	109
Omeprazole	Omeprazole	327	94
Metoprolol Succinate	Metoprolol Succinate	326	96
Amlodipine Besylate	Amlodipine Besylate	292	85
Alendronate Sodium	Alendronate Sodium	205	60
Gabapentin	Gabapentin	181	55
Trazodone Hcl	Trazodone Hcl	152	50
Potassium Chloride	Potassium Chloride	141	40
Lisinopril	Lisinopril	139	39
Olmesartan Medoxomil	Olmesartan Medoxomil	139	36
Hydrochlorothiazide	Hydrochlorothiazide	135	38
Metformin Hcl	Metformin Hcl	127	32
Furosemide	Furosemide	118	33
Sertraline Hcl	Sertraline Hcl	107	33
Pravastatin Sodium	Pravastatin Sodium	99	28
Albuterol Sulfate Hfa	Albuterol Sulfate	96	44
Metformin Hcl Er	Metformin Hcl	96	28
Eliquis	Apixaban	93	24
Fluticasone Propionate	Fluticasone Propionate	92	43
Duloxetine Hcl	Duloxetine Hcl	86	25
Montelukast Sodium	Montelukast Sodium	81	22
Pantoprazole Sodium	Pantoprazole Sodium	75	17
Escitalopram Oxalate	Escitalopram Oxalate	74	14
Atenolol	Atenolol	65	19
Bupropion Xl	Bupropion Hcl	60	23
Clopidogrel	Clopidogrel Bisulfate	60	17
Simvastatin	Simvastatin	55	15
Fluoxetine Hcl	Fluoxetine Hcl	54	18
Allopurinol	Allopurinol	52	14
Xarelto	Rivaroxaban	52	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	51	14
Spironolactone	Spironolactone	49	14
Propranolol Hcl	Propranolol Hcl	48	20
Buspirone Hcl	Buspirone Hcl	47	15
Estradiol	Estradiol	47	23
Lovastatin	Lovastatin	46	12
Ondansetron Odt	Ondansetron	44	17
Cefadroxil	Cefadroxil	43	35
Famotidine	Famotidine	42	16
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	42	suppressed
Ozempic	Semaglutide	42	suppressed
Carvedilol	Carvedilol	41	12
Mirtazapine	Mirtazapine	41	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	41	11
Venlafaxine Hcl Er	Venlafaxine Hcl	37	12
Aripiprazole	Aripiprazole	36	suppressed
Prednisone	Prednisone	35	26
Synthroid	Levothyroxine Sodium	35	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	35	14
Torsemide	Torsemide	33	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	32	13
Progesterone	Progesterone, Micronized	32	suppressed
Trulicity	Dulaglutide	32	suppressed
Jardiance	Empagliflozin	31	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	28	26
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Clonazepam	Clonazepam	26	suppressed
Fluconazole	Fluconazole	26	14
Memantine Hcl	Memantine Hcl	26	suppressed
Propranolol Hcl Er	Propranolol Hcl	26	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	25	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	25	suppressed
Acyclovir	Acyclovir	23	14
Diclofenac Sodium	Diclofenac Sodium	23	14
Metoprolol Tartrate	Metoprolol Tartrate	22	11
Rizatriptan	Rizatriptan Benzoate	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	suppressed
Ezetimibe	Ezetimibe	21	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	13
Alprazolam	Alprazolam	19	suppressed
Celecoxib	Celecoxib	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Glimepiride	Glimepiride	19	suppressed
Ipratropium Bromide	Ipratropium Bromide	19	suppressed
Mounjaro	Tirzepatide	19	suppressed
Ramipril	Ramipril	19	suppressed
Terbinafine Hcl	Terbinafine Hcl	19	suppressed
Glipizide Er	Glipizide	18	suppressed
Nystatin	Nystatin	18	12
Loperamide	Loperamide Hcl	17	suppressed
Norethindron-Ethinyl Estradiol	Norethindrone Ac/Eth Estradiol	17	suppressed
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Verapamil Er	Verapamil Hcl	17	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	12
Finasteride	Finasteride	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Folic Acid	Folic Acid	15	suppressed
Glipizide	Glipizide	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Lacosamide	Lacosamide	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Nitroglycerin	Nitroglycerin	15	13
Pregabalin	Pregabalin	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	13
Carbamazepine	Carbamazepine	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Lorazepam	Lorazepam	14	suppressed
Memantine Hcl Er	Memantine Hcl	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Valsartan	Valsartan	13	suppressed
Azithromycin	Azithromycin	12	11
Baclofen	Baclofen	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Naproxen	Naproxen	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Premarin	Estrogens, Conjugated	11	suppressed
Tramadol Hcl	Tramadol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error